Download PDF
CC BY-NC-ND 4.0 · International Journal of Epilepsy 2015; 02(01): 019-027
DOI: 10.1016/j.ijep.2015.02.004
Original Article
Thieme Medical and Scientific Publishers Private Ltd.

Pharmacognostic, physicochemical and phytochemical investigation of Bacopa monnieri L. stem and its anticonvulsant potential in laboratory animals

Amrita Mishra
a   Department of Pharmacognosy, School of Pharmaceutical Sciences, IFTM University, Moradabad 244001, India
,
Arun K. Mishra
a   Department of Pharmacognosy, School of Pharmaceutical Sciences, IFTM University, Moradabad 244001, India
,
Om PrakashTiwari
a   Department of Pharmacognosy, School of Pharmaceutical Sciences, IFTM University, Moradabad 244001, India
,
Shivesh Jha
b   Department of Pharmaceutical Sciences, Birla Institute of Technology, Ranchi 835215, India
› Author Affiliations
Further Information

Publication History

Received: 06 June 2014

Accepted: 14 February 2015

Publication Date:
05 May 2018 (online)

   Permissions and Reprints

Abstract

Aim The aim of present work was to study the pharmacognostic standardization, physicochemical, phytochemical and pharmacological evaluation of the stem of Bacopa monnieri L.

Method Standard method was followed for pharmacognostic, physicochemical, and phytochemical study. For quantitative analysis, HPTLC technique was employed. Maximal electroconvulsive shock (MES) and pentylenetetrazole (PTZ) method was used for anticonvulsant evaluation.

Result Microscopic study of the stem showed presence of epidermis and cortex having large intercellular spaces. The oval shaped starch grains were present in cells of cortex and endodermis. Total ash (5.98%), water-soluble ash (4.91%), acid-insoluble ash (3.96%), water soluble extractive (15.31%) and ethanol soluble extractive (6.74%) values were evaluated for physicochemical evaluations. Quantitative estimation of Bacoside A (marker compound) by HPTLC technique was performed. The linearity (100–600 ng), the % recovery (97.81% w/w) were estimated. The Bacoside A in the alcoholic extract was found to be higher than that of the other extracts. The proposed HPTLC method was found to be simple and accurate. The anticonvulsant activities of all the extracts were evaluated by MES and PTZ models in mice.

Conclusion The least anticonvulsant potential was recorded for acetone extract in dose of 100 mg/kg and maximum anticonvulsant action was recorded for ethanolic extract in dose of 300 mg/kg.

Keywords

Bacopa monnieri L. - Bacoside A - HPTLC - Anticonvulsant
 

  • References

  • 1 Russo A, Izzo AA, Borrelli F. et al. Free radical scavenging capacity and protective effect of Bacopa monnieri L. on DNA damage. Phytother Res 17 2003; 870-875
    CrossrefPubMedGoogle Scholar
  • 2 Singh HK. Brain enhancing ingredients from Āyurvedic medicine: quintessential example of Bacopa monnieri, a Narrative review. Nutrients 5 2013; 478-497
    CrossrefPubMedGoogle Scholar
  • 3 Singh RH, Singh L. Studies on the anti-anxiety effect of the medyha rasayana drug Brahmi (Bacopa monniera Wettst). Res Ayu Siddha 1 1980; 133-148
    PubMedGoogle Scholar
  • 4 Shinomol GK, Muralidhara. Bharath MM. Exploring the role of “Brahmi” (Bocopa monnieri and Centella asiatica) in brain function and therapy. Recent Pat Endocr Metabolic Immune Drug Discov 5 2011; 33-49
    PubMedGoogle Scholar
  • 5 Saxena VS, Nadkarni VV. Nonpharmacological treatment of epilepsy. Ann Indian Acad Neurol 14 2011; 148-152
    CrossrefPubMedGoogle Scholar
  • 6 Chumbhalea DS, Upasanib CD. Pharmacognostic standardization of stems of Thespesia lampas (Cav.) Dalz & Gibs. Asian Pac J Trop Biomed 2 2012; 357-363
    CrossrefPubMedGoogle Scholar
  • 7 Jhade D, Ahirwar D, Jain R, Sharma N, Gupta S. Pharmacognostic standardization, physico- and phytochemical evaluation of Amaranthus spinosus Linn. Root. J Young Pharm 3 2011; 221-225
    PubMedGoogle Scholar
  • 8 Seidel V. Initial and bulk extraction of natural products isolation. Methods Mole Biol 864 2012; 27-41
    PubMedGoogle Scholar
  • 9 Shabbir M, Rashid M. Assessment of phytochemicals, antioxidant, anti-lipid peroxidation and anti-hemolytic activity of extract and various fractions of Maytenus royleanus leaves. BMC Complement Altern Med 13 2013; 143-147
    CrossrefPubMedGoogle Scholar
  • 10 Sharma P, Sharma JD. In vitro hemolysis of human erythrocytes by plant extracts with antiplasmodial activity. J Ethnopharmacol 74 2001; 239-243
    CrossrefPubMedGoogle Scholar
  • 11 Hassan MM, Oyewale AO, Amupitan JO, Abduallahi MS, Okonkwo EM. Preliminary phytochemical and antibacterial investigation of crude extracts of the root bark of Detarium microcarpum. J Chem Soc Niger 29 2004; 26-29
    PubMedGoogle Scholar
  • 12 Usman H, Abdulrahman FI, Usman A. Qualitative phytochemical screening and in vitro antimicrobial effects of methanol stem bark extract of Ficus Thonningii (Moraceae). Afri J Trad Comp Altern Med 6 2009; 289-295
    PubMedGoogle Scholar
  • 13 Lipnick RL, Cotruvo JA, Hill RN. et al. Comparison of the up-and-down, conventional LD50, and fixed-dose acute toxicity procedures. Food Chem Toxicol 33 1995; 223-231
    CrossrefPubMedGoogle Scholar
  • 14 Yue W, Liu WH, Wang LF. et al. Acute toxicity testing (LD50) of Chinese mineral drugs. Zhongguo Zhong Yao Za Zhi 14 1889; 42-45
    PubMedGoogle Scholar
  • 15 Ferraro TN, Golden GT, Smith GG. et al. Mouse strain variation in maximal electroshock seizure threshold. Brain Res 936 2002; 82-86
    CrossrefPubMedGoogle Scholar
  • 16 Pathak S, Wanjari MM, Jain SK, Tripathi M. Evaluation of antiseizure activity of essential oil from roots of Angelica archangelica Linn. in mice. Ind J Pharma Sci 72 2010; 371-375
    PubMedGoogle Scholar
  • 17 Sahu S, Dutta G, Mandal N. et al. Anticonvulsant effect of Marsilea quadrifolia Linn. on pentylenetetrazole induced seizure: a behavioral and EEG study in rats. J Ethnopharmacol 141 2012; 537-541
    CrossrefPubMedGoogle Scholar
  • 18 Hosseinzadeh H, Parvardeh S. Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice. Phytomed 11 2004; 56-64
    CrossrefPubMedGoogle Scholar
  • 19 ICH Guidance for Industry, Q1B: Photo Stability Testing of New Drug Substances and Product, International Conference on Harmonization. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm073373.pdf
    PubMed
  • 20 Urbani A, Belluzzi O. Riluzole inhibits the persistent sodium current in mammalian CNS neurons. Eur J Neurosci 12 2000; 3567-3574
    CrossrefPubMedGoogle Scholar
  • 21 Ghasemi M, Schachter SC. The NMDA receptor complex as a therapeutic target in epilepsy: a review. Epilepsy Behav 22 2011; 617-640
    CrossrefPubMedGoogle Scholar
  • 22 Deepak M, Sangli GK, Arun PC. et al. Quantitative determination of the major saponin mixture bacoside A in Bacopa monnieri by HPLC. Phytochem Anal 16 2005; 24-29
    CrossrefPubMedGoogle Scholar
  • 23 Kaushik D, Tripathi A, Tripathi R. et al. Anticonvulsant activity of Bacopa monnieri in rodents. Braz J Pharm Sci 45 2009; 643-649
    CrossrefPubMedGoogle Scholar
  • 24 Giramkar SA, Kulkarni OP, Jagtap SD. et al. Anticonvulsant potential of commonly practiced formulations of Brahmi (Bacopa monnieri Linn.) in Wistar rats. J Pharm Res XX 2013; 1-3
    PubMedGoogle Scholar
  • 25 Kamkaew N, Scholfield CN, Ingkaninan K. et al. Bacopa monnieri and its constituents are hypotensive in anaesthetized rats and vasodilator in various artery types. J Ethanopharmacol 137 2011; 790-795
    PubMedGoogle Scholar
  • 26 Sumathi T, Nongbri A. Hepatoprotective effect of Bacoside-A, a major constituent of Bacopa monniera Linn. Phytomed 15 2008; 901-905
    CrossrefPubMedGoogle Scholar
  • 27 Singh HK, Rastogi RP, Srimal RC. et al. Effect of bacosides A and B on avoidance responses in rats. Phytother Res 2 1988; 70-73
    CrossrefPubMedGoogle Scholar